Has Rachel Cofield, OD received payments from drug or device companies?

Yes. Drug and device makers reported $1,673 in general payments to Rachel Cofield, OD across 19 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rachel Cofield, OD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rachel Cofield, OD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rachel Cofield, OD

Optometrist · Pflugerville, TXNPI 1982278354

Payments from drug & device makers

$1,673in general payments, 2019–2025

Across 19 payments — averaging $88.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bausch & Lomb Americas Inc.$523
Alcon$368
Sun Pharmaceutical Industries Inc.$209
Biotissue Holdings Inc.$193
Coopervision Inc.$148
Amgen$109
plus $123 from 3 others

What the payments were for

Food & beverage$1,65599%
Education$181%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bausch & Lomb Americas Inc.	6	$523
Alcon	3	$368
Sun Pharmaceutical Industries Inc.	2	$209
Biotissue Holdings Inc.	2	$193
Coopervision Inc.	2	$148
Amgen	1	$109
Glaukos Corporation	1	$89
Dompe US, Inc.	1	$20
Johnson & Johnson Vision Care, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,673 in reported general payments places this provider in the 65th percentile of 4,315 optometrist providers in Texas.

See all optometrist providers in Texas →

Medicare billing

Part B allowed, 2024

$11,292

Medicare patients

Services billed

123

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Latanoprost	35	$151
Timolol Maleate	11	$84

Paid to pharmacies, not to this prescriber.

Other optometrist in Pflugerville

Tiffany HuynhHouston$3.2M
Bridgitte LeeHouston$3M
Bryan FrazierTyler$1.4M
Derek CunninghamAustin$940K
Wendy ChungKaty$900K
Phillip BrunsonHouston$766K
Claudio LagunasHouston$644K
Ashley Wallace-TuckerHouston$568K
Mina VanrachackSan Antonio$553K
Luis RojasMcKinney$309K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →